Astrocytes in the developing brain direct neurites through their synthesis of cell surface and extracellular matrix molecules. We introduce a novel culture system to identify and examine the guidance properties of astrocyte-derived molecules. The permissive A7 and nonpermissive Neu7 cell lines were co-cultured to form an A7/Neu7 monolayer. Neurites extended on A7 cells but avoided Neu7 cells and instead stopped or turned at the A7/Neu7 interface. Enzymatic treatment with trypsin and hyaluronic acid increased neurite extension, but neither altered the boundary. Only removal of keratan and chondroitin sulfate residues reduced the guidance capacity of the A7/Neu7 boundary. Since no treatment individually abolished the boundary, neurite guidance appears to be due to a combination of factors. The A7/Neu7 astrocyte substrate demonstrates the functional role for KSPGs and CSPGs, but more interestingly, suggests that simply increasing the capacity of a substrate to permit neurite outgrowth does not necessarily eliminate or even reduce its guidance properties.
INTRODUCTION
The perceived role of astrocytes in the developing brain has evolved from providing a passive support mechanism for neurons to actively functioning in regulating neurite extension and patterning (Rakic, 1971; Steindler et al., 1989b; Snow et al., 1990b; Shiga and Oppenheim, 1991; Silver et al., 1993; Gonzalez and Silver, 1994; Herrup and Silver, 1994; Mittal and David, 1994) . Both in vivo and in vitro experimental approaches have provided evidence which suggests that astrocytes alone can control neurite pathfinding, and thus patterning, in the developing central nervous system (Smith et al., 1986 (Smith et al., , 1990 Steindler et al., 1988; Snow et al., 1990a; Sajin and Steindler, 1994) . While astrocytes overall have been shown to promote neurite extension, and to be an optimal substrate in vitro (Noble et al., 1984; Fallon, 1985) , in vivo studies suggest that select populations of astrocytes may actually restrict neurite extension (Steindler et al., 1989a (Steindler et al., , b, 1990 . The spatial organization of these restricting astrocytes indicates that they form boundaries to neurites and thus may guide neurites by preventing infiltration into specific areas. One example is the rodent somatosensory barrel field, where astrocytes which outline the barrels are believed to organize the neurites into the barrel configuration by preventing extension outside of the barrel ''walls'' . Similar astrocyte boundaries are also found within the striatum (Gates et al., 1993) , spinal cord (Snow et al., 1990b; Silver, 1993) , and retina (Snow et al., 1991; Brittis and Silver, 1995) . Thus, one mechanism by which astrocytes guide neurites may be by forming boundaries or barriers to neurite extension.
The evidence for the functional roles of the boundaryforming astrocytes has come from extensive in vitro studies on extracellular matrix molecules. The capacity of an ECM molecule to support neurite extension has been evaluated with purified molecules on either glass or plastic substrates. From these studies, laminin and fibronectin have been designated as being permissive to neurite extension (Rogers et al., 1983; Lander et al., 1985; Rogers et al., 1987; Hammarback et al., 1988) , while proteoglycans such as chondroitin sulfate proteoglycan (CSPG) and keratan sulfate proteoglycan (KSPG), and possibly tenascin, have been classified as nonpermissive (Faissner and Kruse, 1990; Snow et al., 1990a Snow et al., , 1991 Gotz et al., 1996) . Immunohistochemistry experiments have demonstrated that the boundary-forming astrocytes express the nonpermissive ECM molecules, while other astrocytes do not (Steindler et al., 1990; Laywell et al., 1992; Seo and Geisert, 1995) . Thus the spatial location and ECM expression of the boundary forming astrocytes lend further support to the hypothesis that they can guide neurites by restricting neurite extension.
While these in vivo observations are suggestive of a restrictive role, functional data have been obtained only using in vitro models. However, the plastic nature and the heterogeneity of astrocytes have hindered the study of the precise mechanisms by which astrocytes provide neurite guidance (Smith et al., 1986; Hoke and Silver, 1996) . Organotypic cultures of regions containing the boundary-forming astrocytes, such as the cortical barrel fields, demonstrated a decrease in expression of the putative guidance molecules, such as tenascin and CSPG (Steindler et al., 1990; Gates et al., 1993) . In addition, primary cultures of astrocytes are themselves heterogeneous with very low expression of the putative boundary-forming molecules tenascin, CSPG, or KSPG. Our laboratory has identified a population of primary astrocytes which express high levels of tenascin and CSPG and which appear to form boundaries to neurites (Grierson et al., 1990; Meiners et al., 1995) . However, the paucity of these cells, along with their varied expression levels of the boundary molecules, has hindered extensive studies on their roles in neurite guidance. Primary astrocyte cultures have the additional disadvantage of temporally altering their capacity to support neurite extension: as the primary astrocytes age, their capacity to support neurite extension is decreased. In light of these difficulties, we have taken a new approach to investigating the roles of astrocytes in neurite guidance.
To test the hypothesis that astrocytes guide neurites by selectively restricting neurite extension, we have developed an in vitro model of an astrocyte boundary using immortalized astrocyte cell lines. These wellcharacterized cell lines all express the astrocyte marker glial fibrillary acidic protein (GFAP), but vary in their expression of ECM molecules. For example, the A7 cell line expresses laminin and fibronectin, but not tenascin, CSPG, or KSPG. The A7 cell line supports robust neurite extension in vitro and thus is representative of permissive astrocytes, both in vivo and in primary culture Okoye et al., 1995) . In contrast, the Neu7 cell line expresses tenascin, CSPG, and KSPG, in addition to laminin and fibronectin, and neurite extension on the Neu7 cells is poor (Smith-Thomas et al., 1994; Fok-Seang et al., 1995) . Therefore, these astrocyte cell lines are representative of two of the many types of astrocytes which may be found in vivo. Since choice assays using purified substrates suggest that neurite guidance is the result of the neurite responding to heterogeneous environmental cues, we have thus designed a novel model system which combines the A7 and Neu7 cells in a mixed monolayer configuration (A7/Neu7). Neurites crossing from one cell type to another are therefore encountering changes in their environment which may be similar to those found during development. By making an in vitro astrocyte pattern, we can now evaluate the roles of astrocytes and their capacity to alter the pattern of neurite extension in a defined and controlled manner.
In this study, we have used the A7/Neu7 astrocyte boundary model to study the roles of astrocyte-derived proteoglycans in neurite guidance. First, we demonstrate that the combination of the permissive A7 cells with the nonpermissive Neu7 cells does indeed direct, or alter, the neurite trajectory. Those neurites which encounter the interface between the A7 and the Neu7 cells either stop or turn at the Neu7 cell perimeter; neurite crossing of the boundary was a rare event. Second, biochemical alterations of the substrate demonstrate that proteoglycans are components of the astrocyte boundary. In particular, removal of glycosaminoglycan residues from CSPG and KSPG reduces the A7/ Neu7 boundary and also increases overall neurite extension. However, not all the treatments which increase neurite extension subsequently decrease the astrocyte boundary. From these studies, we hypothesize that simply increasing the permissivity of a substrate is not sufficient to reduce or eliminate the guidance capacity of the boundary-forming astrocytes, and thus while the neurites may grow faster and appear longer, they still turn at the astrocyte boundary. This cellular model provides a method to evaluate the roles of several putative guidance molecules in neurite guidance and pathfinding in the developing central nervous system.
RESULTS

A7 and Neu7 Cells Support Cerebral Cortical Neurite Outgrowth
Our previous studies demonstrated that A7 cells promoted neurite outgrowth from dorsal root ganglion and retinal neurons of both postnatal and embryonic origin, while Neu7 cells were significantly less permissive than A7 cells . We therefore evaluated the capacity of these cells to support the growth of E17 rat cerebral cortical neurons. Neurons were plated onto confluent monolayers of either A7 or Neu7 cells, and the living neurons were examined after 20 h with differential interference contrast (DIC) optics (Fig. 1) . Neurons on both A7 and Neu7 cells extended processes, but neurites on the A7 cells appeared longer (Figs. 1A and 1C) .
While major processes were easily seen with DIC optics, the fine neuritic processes were difficult to distinguish from the underlying astrocytic monolayer. To enhance visualization of the neurites, the cultures were incubated with the vital dye CFDA, which selectively labels neurons (Petroski and Geller, 1994) . CFDA labeling revealed the entire neuritic process, from the soma to the growth cone (Figs. 1C and 1D ). On both substrates, the neurites projected in relatively straight paths from the cell soma, and the thickness of the neurites appeared to be similar. On the other hand, the generation of neurites over the first 24 h was enhanced on A7 cells: Ͼ90% of the neurons on the A7 cells extended processes, compared to Ͻ60% on the Neu7 monolayer.
Neurite Outgrowth Is Decreased on Mixed Monolayers of A7 and Neu7 Cells
After ascertaining that Neu7 cells were less permissive than A7 cells, we evaluated whether the combination A7/Neu7 would reduce neurite outgrowth compared to pure A7 cells. A7 cells were plated onto polylysine-coated coverslips. After 24 h, Neu7 cells were labeled with 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate (DiI) and added to the previously plated A7 cells. After the cells reached confluence, neurons were plated on the A7/Neu7 monolayer and labeled with CFDA. In this culture system, neurons can be distinguished from astrocytes both with DIC optics ( Fig. 2A) and with epifluorescent illumination and a fluorescein filter set (Fig. 2B) . Likewise, the Neu7 cells could be distinguished from the A7 cells; when observed with epifluorescent illumination and a rhodamine filter set, the DiI-labeled Neu7 cells appeared bright red (Fig. 2C) while the unlabeled A7 cells did not fluoresce. DiI-labeling and simultaneous nuclear DAPI staining revealed that A7 cells constituted 90% of the monolayer (data not shown). The remaining 10% of the cells consisted of sparse islands of one to five Neu7 cells. Neurites on A7 portions of the substrates were visibly longer than neurites on the Neu7 portions, displaying the same trend as neurites on pure monolayers of either A7 or Neu7 cells (data not shown).
The distribution of total neurite length on the A7/ Neu7 monolayer was compared to the total neurite length on pure monolayers of A7 and Neu7 cells (Fig. 3) . Neurite lengths did not follow a normal distribution, and the data are therefore presented as box and whisker plots. The boxes enclose the 25th and 75th percentiles of the distributions; the median is marked by the vertical line in the box, while the error bars denote the 5th and 95th percentiles. Neurites are longest on pure monolayers of A7 cells with a median length of 79 µm. The shortest neurites, median length 32 µm, were found on pure Neu7 monolayers. As expected, neurite length on the A7/Neu7 substrate was intermediate, with a median length of 49 µm.
We sought to determine the factors responsible for the decreased neurite outgrowth on A7/Neu7 mixed monolayers. Neu7 cells have been reported to express soluble proteoglycans which partially block the promotory neurite outgrowth effects of laminin and also partially block the neurite outgrowth-promoting effects of A7 conditioned medium (CM) (Smith-Thomas et al., 1994) . To determine if the decrease in neurite length observed on the A7/Neu7 substrate was due solely to soluble factors produced by the Neu7 cells, neurite outgrowth was measured on A7 cells in the presence of A7/Neu7 CM, which represents the combination of factors in the A7/Neu7 mixed monolayer. The median neurite length of 58 µm observed in the presence of A7/Neu7 CM (A7 ϩ A7/Neu7 CM) was still greater than the 49-µm length on the A7/Neu7 monolayer. Likewise, neurite outgrowth on A7 cells in the presence of pure Neu7 conditioned medium (A7 ϩ Neu7 CM) also displayed decreased lengths, with a median length of 40 µm. All distributions were significantly different (K-S, P Ͻ 0.01). Hence, soluble factors in Neu7 CM did decrease neurite outgrowth, but not to the full extent observed on the Neu7 substrate. This suggests that substrate-bound factors, either ECM or cell surface molecules, provide additional inhibitory factors.
Neu7 Cells Form a Barrier to Neurite Outgrowth
Previous characterization has demonstrated that Neu7 cells produced more of the ECM proteoglycans, including chondroitin-6-sulfate proteoglycan, than did A7 cells (Smith-Thomas et al., 1994) . CSPG, along with KSPG, is expressed by boundary-forming astrocytes during development; many experiments indicate that proteoglycans retard axonal growth and thus prevent neurite infiltration into certain areas, therefore providing guidance via inhibition (Silver, 1994; Gates et al., 1995; Seo and Geisert, 1995; Snow et al., 1996) . Thus, we hypothesized that Neu7 cells, with their expression of 
FIG. 3.
Neurite outgrowth on A7 cells was reduced in the presence of Neu7 and A7/Neu7 conditioned medium. Neurons were plated on A7 cells, Neu7 cells, the A7/Neu7 mixed monolayer, A7 cells with A7/Neu7 conditioned medium (A7 ϩ A7/Neu7 CM), or A7 cells with Neu7 conditioned medium (A7 ϩ Neu7 CM), and neurite extension was analyzed after 30 h. While the A7/Neu7 CM reduced neurite outgrowth, compared to A7 cells alone, a greater reduction was found on the A7/Neu7 mixed monolayer.
inhibitory molecules, may also have the capacity to direct neurites. Hence we closely examined the behavior of neurites which originated on A7 cells but were within 10 µm of a Neu7 cell (Hotary and Tosney, 1996) . If the Neu7 cells did form barriers, neurites growing on the A7 cells would be expected to alter their trajectories upon encountering the Neu7 cells.
Consistent with this hypothesis, neurite trajectories on pure monolayers were relatively straight and randomly oriented, whereas the trajectories on mixed A7/Neu7 monolayers displayed several different behaviors. While some neurites had straight trajectories which ended at the Neu7 cell (Fig. 4A ), the majority of neurites had paths which turned at the Neu7 cell and continued along its perimeter (Fig. 4B ). This turning response was always found at the edge of the Neu7 cell; in some cases, the curvature of the turn was approximately 90°. Moreover, very few neurites crossed onto the Neu7 cell ( Fig.  4C ). Neurites growing on A7 cells that were not in close proximity to Neu7 cells did not turn away from the Neu7 cell. The few neurites that originated on the Neu7 cells did not turn once they encountered the A7 cells; instead, neurites from Neu7 cells simply crossed the A7/Neu7 interface onto the A7 cell (data not shown). Overall, neurites on the A7/Neu7 monolayer, especially at the interface between cell types, displayed different outgrowth patterns than those on pure A7 and Neu7 monolayers.
We quantified the percentage of neurites within 10 µm of the A7/Neu7 interface as stopped, turned, or crossed (Fig. 5 ). Stopped neurites were neurites with straight trajectories which terminated at the Neu7 cell. Since this is a static assay, the stopped neurites may have just reached the Neu7 cell or they may have resided at the boundary of the A7 and Neu7 cells for several minutes or hours. The stopped neurites displayed large, welldefined growth cones. Thus, neurite stopping did not appear to be due to growth cone collapse. Turned neurites displayed a change in the neurite trajectory at the A7/Neu7 interface; the angle of the turns varied from approximately 20°to 90°. Finally, crossed neurites were those which resided on both the A7 and the Neu7 cells. On A7/Neu7 mixed monolayers, 35% of the neurites stopped, 60% turned and extended along the Neu7 cell, and Ͻ5% crossed the A7/Neu7 interface. To ensure that the DiI labeling of the Neu7 cells was not responsible for these behaviors, control substrates were also examined. An A7/A7-DiI substrate was generated by plating DiI-labeled A7 cells onto a monolayer of unlabeled A7 cells; similarly, a Neu7/Neu7-DiI substrate was created by combining unlabeled and DiIlabeled Neu7 cells. The percentages of neurites which stopped, turned, and crossed were 10, 10, and 80%, respectively, on both the A7/A7-DiI and the Neu7/ Neu7-DiI control substrates. Behavior on the control substrates was significantly different from that on the A7/Neu7 monolayer as determined by one-way ANOVA (P Ͻ 0.01). The percentage of neurites that turned was increased on the A7/Neu7 substrate from 10 to Ͼ60%, or a 6-fold increase; neurite crossing was decreased by more than 10-fold over that of control. While these experiments were performed with rat cerebral cortical neurons, we obtained similar results with rat hypothalamic and dorsal root ganglion neurons (data not shown). We have performed additional experiments with mixed monolayers of astrocytes and cell lines which are permissive to neurite outgrowth and do not express the putative guidance proteoglycans; these substrates did not yield boundaries to neurite extension nor induce neurite turning (data not shown). On this basis, the molecules produced by the Neu7 cells in the A7/Neu7 mixed monolayers appeared to form a barrier to the neurites: most neurites stopped or turned and did not cross onto the Neu7 cells.
Proteoglycans Are a Component of the A7/Neu7 Boundary
Previous work demonstrated that neurite outgrowth was increased when Neu7 cells were treated with either xylosides or sodium chlorate, both proteoglycan synthesis inhibitors . We therefore hypothesized that proteoglycans may be instrumental in forming the A7/Neu7 boundary; if so, preventing proper proteoglycan expression would result in a loss of the A7/Neu7 boundary, and thus, neurite behavior on the A7/Neu7 substrate should approach that on pure monolayers. Xylosides interfere with attachment of the glycosaminoglycan (GAG) side chains to the core protein, while sodium chlorate inhibits sulfation of the GAG, resulting in loss of negative charge and in alteration of the three-dimensional structure. Neurite behavior at the A7/Neu7 boundary was therefore evaluated on control monolayers and A7/Neu7 substrates that had been treated with 4-methylumbelliferyl-␤-D-xyloside (Mu), p-nitrophenyl-␤-D-xylopyranoside (PNP), or sodium chlorate. These treatments resulted in a significant reduction in the percentage of neurites which stopped and turned and a concomitant increase in the percentage of neurites which crossed (Fig. 6) . Treatment with sodium chlorate had the greatest effect, decreasing the percentage of neurites which stopped from 35 Ϯ 2.1% (mean Ϯ SEM) to 30 Ϯ 1.6% (P Ͻ 0.01), decreasing the percentage that turned from 65 Ϯ 1.7% to 46 Ϯ 1.3% (P Ͻ 0.01), and increasing those which crossed from 5 Ϯ 1.3% to 25 Ϯ 1.8% (P Ͻ 0.001). Although both Mu and PNP were less efficacious, the overall patterns of neurite behavior were all significantly different than those of FIG. 5. Neurite outgrowth is altered at the A7/Neu7 interface. Neurons were plated onto cellular substrates and allowed to extend processes for 24 h. On the A7/Neu7 substrate, 35% of the neurites stopped at the interface, Ͼ60% turned, and Ͻ5% of the neurites crossed the Neu7 cells. On homogeneous control substrates (A7/A7-DiI and Neu7/Neu7-DiI), approximately 10% of the neurites stopped or grew along the interface, while 80% crossed the interface. At least six coverslips were scored per condition; the error bars depict the SEM.
FIG. 6.
Neurite avoidance of the A7/Neu7 boundary is partially due to proteoglycans. Neurons were plated on A7/Neu7 substrates which were previously treated with 4-methylumbelliferyl-␤-D-xyloside (Mu), p-nitrophenyl-␤-D-xylopyranoside (PNP), or sodium chlorate (Na chlorate). All three treatments, which interrupt normal proteoglycan synthesis and alter the ECM, significantly decreased neurite avoidance at the boundary and increased the percentage of neurites which crossed (P Ͻ 0.01, S-N-K test). At least six coverslips were scored for each condition; the error bars depict the SEM.
control (P Ͻ 0.01). Since the xylosides may also have effects on the cells other than altering proteoglycan assembly, we examined the neurite behavior on A7/ Neu7 monolayers treated with the isomer p-nitrophenyl-␣-D-xylopyranoside (␣PNP), which has been reported not to interfere with GAG addition to the core protein in several cell types, including the glial cell line RC-6 (Schwartz et al., 1974) . All three parameters were not significantly different than control values: stopped (30 Ϯ 3.4%), turned (68 Ϯ 4.1%), and crossed (3 Ϯ 0.8%). In agreement with previous work , overall neurite outgrowth on A7/Neu7 substrates was increased after Mu, PNP, and sodium chlorate treatment (data not shown). When the A7/Neu7 cells were treated with the inactive ␣PNP isomer, neurite outgrowth values were the same as those of control. However, none of the treatments completely eliminated the boundary: in the control A7/A7 monolayer, the percentage of neurites that crossed was 80%. Thus, while the xyloside treatments may have interrupted the proper processing of the proteoglycans, some intact proteoglycans, as well as the core proteins, may have still have resided on the cell surface. Therefore, the A7/Neu7 boundary is composed, at least partially, of proteoglycans expressed by the Neu7 cells.
Enzymatic Removal of Keratan and Chondroitin Sulfate Enhances Neurite Crossing at the Boundary
The alteration of the neurite behavior at the A7/Neu7 boundary after nonspecific reduction of proteoglycan assembly supports the role of these molecules in boundary formation. In previous experiments, treatment of Neu7 ECM with enzymes that remove select sugar side chains resulted in an increased ability of the Neu7 matrix to support neurite outgrowth (Smith-Thomas et al., 1994) . We therefore performed a series of experiments to evaluate the effects of treatment with these enzymes on neurite behavior at the A7/Neu7 boundary. Treatment with either keratanase or chondroitinase ABC decreased the fraction of neurites which either turned or stopped at the boundary and increased the fraction which crossed (Fig. 7) . In comparison, chondroitinase   FIG. 7 . The A7/Neu7 boundary is reduced with keratanase and chondroitinase ABC treatments. The chondroitin sulfate and keratan sulfate side chains were enzymatically removed from A7/Neu7 monolayers before neurons were plated. After 24 h, neurite behavior was evaluated on treated and control monolayers. Twice as many neurites on chondroitinase ABC-and keratanase-treated monolayers crossed the A7/Neu7 boundary than on the untreated A7/Neu7 control. Combined chondroitinase ABC and keratanase treatment further increased the percentage of crossed neurites. However, neither enzyme treatment, alone or in combination, returned the percentage of stopping, turning, or crossing neurites to the levels of the homogeneous substrates (A7/A7-DiI or Neu7/Neu7-DiI). The asterisks depict neurite behavior which was significantly different from that of the A7/Neu7 control (P Ͻ 0.05, S-N-K test). At least five coverslips were scored for each treatment; error bars depict the SEM. AC treatment had a smaller effect on neurite behavior, only slightly increasing neurite crossing. The chondroitinase ABC enzyme removes both chondroitin sulfate (CS) and dermatan sulfate side chains from proteoglycans, while chondroitinase AC liberates only the chondroitin sulfate A and C side chains, leaving the chondroitin sulfate B and dermatan sulfate residues intact. Treatment of A7/Neu7 monolayers with hyaluronidase (5 U/ml), heparitinase I (0.1 U/ml), or heparinase (0.2 U/ml), which cleave hyaluronic acid, heparan sulfate (HS) and heparin side chains, respectively, did not result in any differences in neurite behavior (data not shown).
(The concentrations of all enzymes were chosen based on a previous study which demonstrated that these treatments markedly increased neurite extension on the Neu7 cells (Smith-Thomas et al., 1994) .) Thus, both KSPG and CSPG are functional components of the A7/Neu7 barrier.
Since treatment with either keratanase or chondroitinase ABC alone only partially reduced the A7/Neu7 boundary, the combined treatment with both enzymes was expected to further weaken the barrier. Consistent with this hypothesis, the combination of keratanase and chondroitinase ABC treatment further reduced the fractions of stopped and turned neurites while increasing the neurites that crossed the A7/Neu7 boundary. Neurite behavior after treatment with keratanase and chondroitinase AC was not significantly different from keratanase treatment alone (P Ͼ 0.8). While the greatest percentage of neurites crossed the A7/Neu7 boundary after treatment with a combination of keratanase and chondroitinase ABC (44 Ϯ 3.1%), this percentage is still much lower than that on pure monolayers (80 Ϯ 1.6%).
One possible explanation is that the sugar residues are not fully removed or that they regenerate during the course of the experiment. We therefore examined the time course of return of either the chondroitin sulfate or the keratan residues after removal with either chondroitinase ABC or keratanase, respectively. We utilized immunocytochemistry with the CS56 monoclonal antibody, which detects chondroitin sulfate residues. Untreated Neu7 cells displayed immunoreactive fibrils and punctate deposits (Fig. 8A) , while the A7 cells showed low levels of immunoreactivity in the form of punctate deposits (Fig. 8E) . Immediately after chondroitinase ABC digestion, no immunoreactivity was observed on either Neu7 (Fig. 8B ) or A7 cells (Fig. 8F) . Twenty-four hours after digestion, the time frame of the boundary experiments, faint punctate immunoreactivity suggested that few chondroitin sulfate residues had reappeared on the cell surface of the Neu7 cells (Fig. 8C) , while no immunoreactivity was detected on the A7 cells (data not shown). After 48 h, the pattern of immunoreactivity indicated that the Neu7 CSPGs had begun to assemble into fibrils (Fig. 8D) , although there were fewer fibrils and the intensity was less than on the untreated Neu7 cells. These experiments thus confirmed that chondroitin sulfate residues were removed by the chondroitinase ABC treatment. Our immunocytochemistry techniques detected only minimal amounts of reexpressed CSPG after 24 h. The chondroitin sulfate residues reappeared between 24 and 48 h after enzy-FIG. 8. Chondroitin sulfate residues are removed by chondroitinase ABC. Monolayers of either Neu7 or A7 cells were digested with chondroitinase ABC and then probed with the CS56 monoclonal antibody which detects the chondroitin sulfate residue. The untreated Neu7 monolayer shows prominent CSPG fibrils (A). Immediately following digestion, no immunoreactivity is observed (B). Twentyfour hours after digestion very little CSPG has reappeared (C), while more immunoreactivity is observed 48 h postdigestion (D). Untreated monolayers of A7 cells display very little CSPG (E), while none is seen after chondroitinase ABC digestion (F). Bar, 10 µm. matic treatment, which was beyond the time frame of our experiments.
Similarly, we examined the efficacy of the keratanase treatment. Confluent monolayers of A7 and Neu7 cells were treated with keratanase to remove the keratan sulfate (KS) residues. Immunocytochemistry with the 8-C-2 monoclonal antibody demonstrated that Neu7 cells expressed KSPGs (Fig. 9A) , while very little KSPG was detected on A7 cells (Fig. 9E) . The keratanase treatment removed the majority of the KSPG from the Neu7 cells as seen by the faint immunoreactivity (Fig.   9B ), while for A7 cells no difference was seen between untreated and keratanase-digested (Fig. 9F ) cells. KSPG reappearance was observed 24 (Fig. 9C ) and 48 h (Fig.  9D ) after KS removal; however, the extent and pattern of immunoreactivity were much weaker than those for the untreated cells. Again, the KS reappearance, as detected by immunocytochemistry, occurred outside the time frame of our experiments. Therefore, the enzyme digestion protocols removed both the CS and the KS residues from the cell surface, and these GAGs were minimally regenerated over the course of the experiment. However, resynthesis of the proteoglycan may be contributing to the A7/Neu7 boundary effect, and thus preventing complete reduction of the boundary effect, during the course of the experiment. Even so, we can conclude that proteoglycans, specifically keratan sulfate and chondroitin sulfate proteoglycans, function to form a barrier which prevents neurites from crossing from A7 cells to Neu7 cells.
The Neu7 cells have been reported to produce a soluble factor which blocks the neurite-promoting action of laminin. To determine whether this factor, which was also found in the ECM, was responsible for the neurite turning at the boundary, the A7/Neu7 monolayers were treated with trypsin to reduce this lamininblocking activity (Smith-Thomas et al., 1994) . While short-term trypsin treatment (100 µg/ml for 3 h, followed by a medium change) did not decrease the amount of soluble factor produced by the Neu7 cells during the course of the experiment, trypsin treatment reduces the concentration of the inhibitory factor in the ECM (Smith-Thomas et al., 1994) . The mild trypsin treatment was sufficient to nonspecifically remove some ECM and cell surface components without detaching the cells from the coverslips. Neither digestion with trypsin nor digestion with the proteases papain or protease K reduced the A7/Neu7 boundary (Fig. 7) .
Mild trypsin treatment has been reported to release protein fragments which contain several GAG chains, including HS and CS (Rapraeger et al., 1985) , therefore acting nonspecifically. In some cases, trypsin digestion halted overall proteoglycan synthesis, although the inhibition was reversible with time (Bartholomew et al., 1985) . To assess if these enzyme treatments altered the A7 and Neu7 ECM, we performed immunocytochemistry on unfixed cells after mild trypsin digestion. Immunoreactivity for CS and KS was assessed with monoclonal antibodies CS56 and 5D4, respectively. The pattern and intensity of immunoreactivity were not significantly altered following trypsin treatment (data not shown). However, we did observe a decrease in laminin immunoreactivity after mild trypsin digestion (data not   FIG. 9 . Keratan sulfate residues are removed by keratanase. Monolayers of either Neu7 or A7 cells were digested with keratanase and then probed with the 8-C-2 monoclonal antibody which detects the keratan sulfate side chains. Untreated Neu7 cells show punctate deposits and fibrils of KSPG. Very little immunoreactivity is seen immediately following digestion (B). Twenty-four hours after digestion little KSPG has reappeared (C), while more is observed 48 h postdigestion (D). Untreated control monolayers of A7 cells display very little KSPG (E), while none is observed after keratanase treatment (F). Bar, 10 µm.
shown). The trypsin treatment nonselectively removed several molecules from the surfaces of both the A7 and the Neu7 cells, which is in contrast to the enzymes which degraded the GAG residues, such as chondroitinase ABC, which affected only the Neu7 cells which expressed the GAGs. Thus, after trypsin treatment, sufficient levels of proteoglycans remained in order to maintain the astrocyte boundary.
Neurite Boundary Crossing Is Not Correlated to Promoting Overall Neurite Outgrowth
While these results confirm a functional role for proteoglycans in forming boundaries which guide neurites, the mechanism of guidance is still unknown. One hypothesis is that the proteoglycans are simply inhibitory to neurite extension; if several proteoglycans display varying degrees of inhibition to neurite outgrowth, then boundaries of different strengths can be formed. We therefore measured the capacity of the A7/Neu7 monolayer to promote neurite extension before and after removal of specific GAG side chains (Table 1) . While several treatments resulted in increased neurite length on the monolayer, this increase reached statistical significance only for trypsin, keratanase, hyaluronidase, and the combination of keratanase and chondroitinase ABC. Neurite length was decreased after treatment with protease K. Figure 10 presents a comparison of neurite outgrowth vs boundary crossing on the treated A7/Neu7 monolayers. A parallel increase in each of these parameters would result in a correlation between increasing neurite length and crossing a boundary. However, only keratanase treatment (either alone or in combination with chondroitinase ABC) increased both neurite outgrowth and boundary crossing. Chondroitinase ABC and chondroitinase AC had significantly increased boundary crossing, but did not affect neurite outgrowth. In contrast, trypsin and hyaluronidase treatment increased neurite outgrowth but had no effect on boundary crossing. Also, protease K treatment, which did not have an effect on boundary crossing, actually decreased neurite outgrowth. From these results, an increase in the neurite outgrowth response on the substrate did not correlate with an increase in neurite crossing or a reduction of the boundary. Thus the A7/Neu7 boundary cannot simply be surmounted by increasing the overall permissivity of the substrate or rate of neurite extension.
DISCUSSION
Astrocytes have been suggested to direct neurons during development by their expression of guidance molecules: the juxtaposition of astrocytes with different levels of permissivity results in the formation of a boundary (Snow et al., 1990b) . We have shown that the astrocyte boundary model, using the A7 and Neu7 cells, alters the trajectories of neurites in vitro: upon reaching the Neu7 cells, most neurites turned and continued to extend along the Neu7 cell perimeter, while others halted; however, few neurites crossed. Treatment of the A7/Neu7 monolayer with xylosides or sodium chlorate increased the number of neurites that crossed onto Neu7 cells, confirming that proteoglycans were a major constituent of the astrocyte boundary. Furthermore, only the removal of chondroitin and keratan sulfate side chains resulted in an increase in neurite crossing. Treatment with several proteases had significant effects on neurite outgrowth, but did not alter boundary crossing. Thus, using this novel system we have shown that the astrocyte-derived ECM molecules CSPG and KSPG can direct axonal growth when presented in a complex milieu. Finally, we have shown that simply increasing the permissivity of the substrate is not sufficient to eliminate or even decrease the boundary.
The initial hypothesis of neurite guidance by astrocyte boundaries was developed from in vivo studies. Immunocytochemical evidence implicated several ECM proteoglycans as guidance cues, but it was, of necessity, descriptive (Steindler et al., 1989a (Steindler et al., , 1990 Oakley and Tosney, 1991; Gong and Shipley, 1996; Hotary and Note. The total neurite length was measured for at least 50 neurons per treatment. Distributions were compared with a KolmogorovSmirnoff test. *Treatments with neurite lengths which are significantly different from those of control (P Ͻ 0.05). Tosney, 1996) . More functional data have been obtained by growing neurons on slices of developing brain. For example, the growth of neurons plated onto slices of the developing cortex was found to differ as a function of the region, and these differences were abolished by removal of CS chains (Emerling and Lander, 1996) . Upon further investigation, the differences in the neurites' response to the CSPG were found to be due to differential expression of CS-binding proteins in the ECM. Thus, this study implies that ECM molecules guide neurites, but the actual actions of CSPG involve additional binding proteins. Additional evidence for astrocyte boundaries has been obtained with cultures of lesioned regions of both rat and mouse brains. In the lesioned model, reactive astrocytes appear to restrict neurite extension by their expression of CSPG and KSPG (McKeon et al., 1991 (McKeon et al., , 1995 Gates et al., 1996) .
Further evidence for boundary-forming astrocytes in vitro was our description of the ''rocky'' phenotype in cultures of primary rat cerebral cortical astrocytes (Grierson et al., 1990) . Neurites avoided astrocytes which had an unusual rough morphology which contrasted with the normal flat and smooth appearance of the surrounding astrocytes (Grierson et al., 1990) . Further studies demonstrated that these astrocytes expressed high levels of both tenascin and CPSG and restricted neurite extension . The characteristics of the tenascin/CSPG-rich astrocytes suggested that they may have formed boundaries to neurites in vivo. However, the paucity and random occurrence of these restrictive astrocytes in primary cultures have prevented extensive studies of neurite behavior at an astrocyte boundary. Thus, while previous in vitro models provided evidence to support the hypothesis that neurites are guided by astrocyte boundaries, their shortcomings have hindered definitive experiments.
In this study, we have employed a strategy of making cellular boundaries with well-characterized astrocytederived cell lines. Immortalized cell lines have been previously used to investigate the roles of astrocytes in regulating neurite extension. However, we chose to combine cell lines of different permissivities and ECM expression to mimic the in vivo situation. From a panel of several immortalized cell lines with varying ECM and capacities to support neurite extension, we combined the permissive A7 cell line with the nonpermissive Neu7 cell line. The Neu7 cells exhibit high expression of the putative boundary-forming proteoglycans CSPG and KSPG, in addition to tenascin, while A7 cells have few if any of these molecules . Thus, Neu7 cells are representative of the boundary-forming astrocytes found in vivo and the restrictive   FIG. 10 . Neurite crossing at the A7/Neu7 boundary is not correlated with neurite length. Neurite length on the A7/Neu7 substrate (x axis) was compared to neurite crossing at the A7/Neu7 boundary ( y axis). An increase in neurite length did not necessarily lead to an increase in the percentage of crossed neurites. Only keratanase treatment, alone or with chondroitinase ABC, increased both neurite length and boundary crossing. The asterisks signify a significant difference in neurite length over that of control (P Ͻ 0.05, K-S test); the daggers a significant difference in percentage of crossed neurites (P Ͻ 0.05, S-N-K test).
tenascin/CSPG-rich astrocytes observed in vitro. The stable nature of the cell lines provides constant levels of expression of the boundary-forming molecules, unlike the diminishing expression witnessed in the organotypic cultures. In addition, the use of the cell lines provides an abundant source of cells, thus preventing the problems encountered with tenascin/CSPG-rich astrocytes present in primary cultures. In this study, we have used this new in vitro astrocyte boundary model to demonstrate that astrocytes do form boundaries and guide neurites by their expression of specific proteoglycans.
The functions of proteoglycans in the astrocyte boundary confirm and extend experiments previously performed with purified molecules on acellular substrates. The simplest tests on homogeneous substrates have shown that neurite extension was decreased on CSPG (Snow et al., 1991) , KSPG (Snow et al., 1990a) , and other cartilage-derived glycosaminoglycans (Verna et al., 1996) . However, the GAG side chains and the core protein of the proteoglycan may have contrasting action on neurite extension (Margolis and Margolis, 1993; Emerling and Lander, 1996) . For example, a core CSPG fraction purified from rat brain promoted neurite extension, whereas the CS residues prevented outgrowth (Iijima et al., 1991) , but the core protein of the NG2 proteoglycan, and not the CS region, was nonpermissive (Dou and Levine, 1994) . It should be noted that results such as these are dependent upon the type of neuron tested: for example, the 6B4 proteoglycan is repulsive to thalamic neurons but permits outgrowth of cortical neurons . In our astrocyte boundary, we have demonstrated that the GAGs provided guidance information, in that removal of CS and KS residues diminished neurite turning. However, since the boundary effect was not completely eliminated, other factors, possibly including the proteoglycan core proteins, may also function as guidance cues. Therefore, our results agree with the previous experiments using purified molecules which suggest that both the core protein and the GAG residue function in axon pathfinding.
While experiments with individual molecules have been useful in assessing the capacity of each to permit neurite extension, these experiments cannot ascertain the function of each molecule in the glial boundaries and neuronal pathfinding. Choice assays, in which the neurite is presented with two ECM molecules, are a better approximation of in vivo boundaries. In these experiments, neurites were observed to stop, and sometimes turn, at the interface between laminin and either CSPG (Snow and Letourneau, 1992) or KSPG (Snow et al., 1990a) , suggesting neurite guidance via inhibition of neurite extension. Interestingly, when neurites were given a choice between laminin and fibronectin, molecules which are both permissive to extension, neurites turned at both interfaces, laminin-fibronectin and fibronectin-laminin (Gomez and Letourneau, 1994) . Thus, even molecules which are permissive for neurite extension seem to have the capacity to provide guidance. However, in our mixed astrocyte substrate model, the combination of A7 cells with primary astrocytes, which represents a difference in fibronectin concentration, did not form a significant boundary. Thus, although paradigms which use purified ECM molecules are informative, they are likely oversimplifications of the in vivo situation. The homogeneous substrates present the molecules to the neurite in a manner which may not physiological, and the choice assays are limited to evaluating the effects of only two molecules at a time. We have shown in our A7/Neu7 boundary model that CSPG and KSPG are functional in the cellular context, where the neurite simultaneously encounters a plethora of environmental cues, only some of which may function in guidance.
Neurite guidance by cellular cues has been well documented in several systems. In the grasshopper limb bud and at the midline of the optic chiasm, neurites change direction only after contacting specific cells, such as guidepost cells (O'Connor et al., 1990; Marcus et al., 1995) . Similarly, the neurite's decision to either cross or turn at the CNS midline in Drosophila appears to be contact-mediated by a cell membrane protein (Tear et al., 1996) . The RAGS protein is another example of a membrane component with guidance properties (Drescher et al., 1995) . Temporal retinal neurons turned when presented with steep concentration gradients of RAGS. With our astrocyte boundary model, the neurite turning response was observed only at the perimeter of the Neu7 cell, suggesting that the guidance cues resided on or very near the cell membrane. The fact that the astrocyte boundary effect was not completely eliminated after removal of the CS and KS residues suggests that other molecules are functioning as guidance cues. Preliminary experiments suggest that GPI-linked molecules on the cell membrane also contribute to our astrocyte boundary. Thus, overall neurite guidance by the astrocyte boundary model appears to be the net result of several molecules.
We designed the astrocyte boundary model to test the hypothesis that neurites are guided by molecules which are repulsive to neurite outgrowth. While we have shown that selective removal of CS and KS residues decreased the boundary effect, and thus diminished the guidance capacity of the astrocyte boundary, we have also demonstrated that simply increasing the permissivity of the substrate did not always reduce the boundary. Neu7 cells produce a soluble factor which blocks the permissive effects of laminin (Smith-Thomas et al., 1994) . If this factor contributed to neurite guidance, we should have observed turning at a distance from the Neu7 cell and not exclusively at the Neu7 perimeter; this behavior was never observed. Additional experiments, in which trypsin was employed to inactivate the effects of this inhibitory factor, demonstrated that the factor decreased only neurite length and had no effect on the boundary. Thus, the inhibitory factor from Neu7 cells appears to regulate outgrowth and not direction.
Increasing the rate of neurite extension may not be sufficient to overcome guidance cues which are presented as boundaries. In the mouse, olfactory neurons which overexpressed GAP-43 (growth-associated protein-43), and thus had an increased growth potential, still respected the in vivo boundaries (Holtmaat et al., 1995) . Neurites found at the rim of the individual glomeruli did not cross this boundary and instead became dystrophic. Thus, increasing the potential for neurite extension did not alter the neurite response to the in vivo guidance cues. Another study, using a modification of the stripe assay, demonstrated that neurons did not always prefer the most permissive substrate. Neurites preferred to extend on membranes derived from their own target regions over pure laminin, even though the neurite speed was higher on the laminin (Bahr and Wizemann, 1996) . The neurites did choose the laminin substrate over other non-targetderived membrane preparations. Thus in this case, factors other than the permissivity of the substrate governed the neurite behavior. Our results also support the hypothesis that increasing the rate of neurite extension may not alter the neurites' response to guidance cues. We have shown that although brain-derived CS and KS can serve as guidance cues when presented by an astrocyte, hyaluronidase treatment, which increased the rate of neurite extension, had little or no effect on reducing the efficacy of the boundary. Thus, some molecules, such as hyaluronic acid residues, may serve to regulate neurite extension, but they do not participate directly in astrocyte boundaries.
In summary, in this study we have introduced the novel approach of investigating neurite guidance by creating a cellular model of the astrocyte boundary. Neurites on the A7/Neu7 substrate are discouraged from crossing from A7 to Neu7 cells and instead turn at the A7/Neu7 interface. This turning response is influenced by KSPG and CSPG as part of the astrocyte ECM. Since the process of neurite guidance is the net result of multiple guidance cues, future studies will elucidate additional components of the astrocyte boundary. With this cellular substrate both the functions of the individual guidance molecules and their interactions with other molecules can easily be assessed. Further characterization of the cell lines may also lead to the discovery of additional guidance cues. In this study we have also shown that molecules which inhibit neurite outgrowth may not also necessarily provide guidance cues, as increasing neurite extension was not sufficient to overcome the astrocyte boundary. This dual analysis to determine the capacity to support neurite extension and the function as a boundary can be performed only in a defined cellular substrate. The A7/Neu7 astrocyte substrate has confirmed the functional role of axonal guidance for astrocytes and their proteoglycans KSPG and CSPG. This cellular boundary model thus provides a favorable paradigm for studying the mechanisms of neurite extension and guidance.
EXPERIMENTAL METHODS
Materials
Timed pregnant Sprague-Dawley rats were purchased from Hilltop Lab Animals, Inc. (Scottsdale, PA). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from GIBCO Laboratories (Grand Island, NY). 1,1Ј-Dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate and 5-phenyl-4-pyridyl-2-oxazole, octadecyl bromide (C 18 PyPO) were obtained from Molecular Probes, Inc. (Eugene, OR). All other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO). Glass coverslips were purchased from Carolina Biological Supply Co. (Burlington, NC).
Cell Culture and Neurite Outgrowth Assays
A7 cells were derived from cultured rat optic nerve cells immortalized with the SV40 large T antigen (Geller and Dubois-Dalcq, 1988 ). Neu7 cells were generated by infecting rat primary cortical astrocytes with a retrovirus carrying the neu oncogene (Smith-Thomas et al., 1994) . A7 and Neu7 cell lines were maintained in DMEM supplemented with 10% FBS (DMEM/10%). Medium was changed every 3 to 4 days, and cells were subcultured every 6 days. For neurite outgrowth assays, low-passage A7 or Neu7 cells were plated onto 12-mm acid-washed, poly-L-lysine-coated coverslips (100 µg/ ml) in 24-well trays (Falcon) at a density of 3.0 ϫ 10 4 cells/well in DMEM/10% and were grown to confluence. Cerebral cortical neuronal cultures were prepared as described by Ventimiglia and Geller (1987) and plated Astrocyte Proteoglycans onto the cellular substrates at a density of 2 ϫ 10 4 cells/well. After 24 h, neurons on A7 and Neu7 cells were labeled with the vital dye 5(6)-carboxyfluorescein diacetate, which intensely stains the soma and processes of living neurons (Petroski and Geller, 1994) . Images were obtained with a 20X objective and analyzed as described . In other experiments, conditioned medium was collected after 2 days from A7 cells, Neu7 cells, or the A7/Neu7 mixed monolayer and added to A7 monolayers immediately prior to plating neurons.
Generation of Cellular Boundaries
Cellular boundaries were generated by first plating A7 cells at a density of 3 ϫ 10 4 cells/coverslip. Twentyfour hours later, Neu7 cells were labeled with the vital dye DiI (Okoye et al., 1994) and plated at a density of 5 ϫ 10 3 cells/coverslip onto coverslips with A7 cells. Using this procedure, the cells formed a mixed monolayer within 24 h. While this monolayer appeared morphologically homogeneous under phase-contrast or DIC optics, the individual Neu7 cells appeared red under epifluorescent illumination with rhodamine optics. This mixed monolayer of A7 and Neu7 cells is referred to as A7/Neu7.
In order to ensure that DiI did not leak to adjacent cells, A7 cells were separately labeled with the blue membrane dye C 18 PyPO (50 mM in DMEM) for 1 h at 37°C and then washed 4ϫ with DMEM/10% prior to the addition of the Neu7 cells. Within 24 h, C 18 PyPO-labeled A7 cells and DiI-labeled Neu7 cells formed a confluent monolayer. When alternately epi-illuminated with either TRITC or DAPI filters, the substrate contained light blue A7 cells and red DiI Neu7 cells. None of the A7 cells contained any particles of DiI (data not shown). Thus DiI did not appear to migrate from the Neu7 cell membranes to the A7 cells.
In the boundary assay experiments with xylosides or sodium chlorate, A7 and Neu7 cells were grown in DMEM/10% with 1 mM 4-methylumbelliferyl-␤-Dxyloside, 1 mM p-nitrophenyl-␤-D-xylopyranoside, 1 mM p-nitrophenyl-␣-D-xylopyranoside, or 20 mM sodium chlorate for at least 8 days with medium changes every 2 days. For boundary assays, A7/Neu7 mixed monolayers were grown in the presence of xyloside or sodium chlorate. Before the neurons were plated the medium was replaced with fresh DMEM/10% without xyloside or sodium chlorate.
Enzymatic Treatment of Monolayers
Confluent A7/Neu7 monolayers on 12-mm coverslips were treated with enzymes to remove the glycosaminoglycan side chains from the surface proteoglycans. The medium was aspirated off the monolayers and replaced with an enzyme solution: chondroitinase ABC (0.2 U/ml), chondroitinase AC (0.2 U/ml), keratanase (0.5 U/ml), hyaluronidase (5.0 U/ml), heparinase III (1.0 U/ml), heparitinase (1.0 U/ml), a combination of chondroitinase ABC (0.2 U/ml) and keratanase (0.5 U/ml), or a combination of chondroitinase AC (0.2 U/ml) and keratanase (0.5 U/ml). All enzymes were diluted in Tris-acetate buffer, pH 8.0. Other monolayers were treated with buffer alone or with trypsin (100 µg/ml), papain (10 µg/ml), or protease K (10 µg/ml) in Tris-acetate buffer. Cells were incubated with enzyme solutions for 3 h at 37°C and then rinsed with DMEM/ 10% medium before neurons were plated (3 ϫ 10 4 neurons per coverslip). Twenty-four hours after being plated, the neurons were labeled with CFDA and the trajectory of the neurites at the A7/Neu7 interface or the neurite lengths were analyzed.
For immunocytochemistry experiments, pure monolayers of either A7 or Neu7 cells were treated with either chondroitinase ABC (0.2 U/ml) or keratanase (0.5 U/ ml) for 3 h at 37°C. The cells were rinsed with PBS, fed with DMEM/10% FBS, allowed to grow for 0, 1, or 2 days in culture, and then incubated with a primary antibody for 0.5 h at 4°C. The CS56 monoclonal antibody (1:100 dilution, Sigma Chemical Co.) was used to detect the chondroitin sulfate (A and C) side chains, while the keratan sulfate residues were detected with the 8-C-2 monoclonal antibody (1:10 dilution, a gift from J. Michael Sorrell, Case Western Reserve University, Cleveland, OH) (Schafer and Sorrell, 1993) . The coverslips were washed three times in PBS and incubated with a Cy5-conjugated goat anti-mouse IgG for 0.5 h at 4°C. The coverslips were rinsed three times and mounted with mounting medium onto glass slides. Images were taken with a Zeiss LSM 410 Laser Scanning Confocal microscope and a 63X objective.
Statistical Analysis
For neurite outgrowth experiments, the distributions of at least 50 neurons per condition were compared using the nonparametric Kolmogorov-Smirnoff test (K-S). For neurite behavior at the A7/Neu7 interface a boundary assay was developed. For each condition, the number of neurites which stopped, turned, or crossed the A7/Neu7 boundary was counted. At least six coverslips were counted for each experiment. Each individual behavior was analyzed separately with a one-way ANOVA followed by the Student-Neuman-Keuls test (S-N-K) for post hoc analysis. All statistical tests were done with StatMost software (DataMost Corp., Salt Lake City, UT).
